In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ReAble, DJO merger gets FTC (Federal Trade Commission) go-ahead:

This article was originally published in Clinica

Executive Summary

ReAble Therapeutics' merger with musculoskeletal and vascular health specialist DJO Incorporated has received the green light from the US Federal Trade Commission, after it granted early termination of the required antitrust waiting period. The deal, which will see private equity company The Blackstone Group acquire Vista, California-based DJO and merge it with ReAble (see Clinica No 1265, p 11), is expected to close in the fourth quarter of 2007, and is worth approximately $1.6bn.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts